BCTX generated a new all-time low at .69 on Monday, after the news of another 12 million stock offering was announced at a price of $1.25. The stock offering was completed on Tuesday and the low held for the rest of the week. Nonetheless, the dilution of the shares is a negative that will not even begin to go away until the company announces benefits from having done that. Having said that, the stock closed near the high of the week, suggesting further upside above last week's high at .84 will be seen this week. Evidently, resistance will now be found at 1.25, meaning that is the target for the next few weeks. On a positive note, the company did announce that they have begun working with the Mayo clinic and given that it is a highly known and well-respected entity, it does suggest that the probabilities favor the company's Cancer drug (already at the beginning of Phase 3, and so far showing very positive results) being a success that could be highly positive to the price of the stock over the long term (by mid 2026). As such, this stock is no longer tradeable for the short-term, but it is a buy and hold product (if you believe in the fundamental outlook for the drug). Evidently, the .69 cent level should now be considered an indicative support level.

LXRX generated a new 33-week intraweek and weekly closing high but closed in the middle of the week's trading range, suggesting equal chances of going above last week's high at 1.43 or below last week's low at 1.05. The stock did generate a new buy signal and a new failure signal (against the bears), both of indicative consequence, meaning that the previous daily and weekly closing highs at .99 and the previous daily and weekly closing low at 1.01, are now decent and indicative weekly close supports. Probabilities do favor those levels being seen before further upside is seen but probabilities also favor the stock continuing its recovery rally thereafter. The short-term upside objective of this breakout is now the 1.60 level with the 200-week MA, currently at 2.04, being the objective to be reached within the next 2-3 months (or less).

TCEHY generated a new 4-month weekly closing high, but then again, it was not decisive given that it was only by $.01 cents. The stock did close near the high of the week, suggesting further upside above last week's high at 66.74 will be seen this week. The Chinese index suggesting further (but limited) action will be seen this week, does suggest the stock will do the same. There is intraweek resistance at 68.53, which if broken would suggest the 4-year high at 71.82 would be tested and likely broken, meaning that a break above 68.53 would be a good reason to consider covering the shorts. To the downside, intraweek support is now found at 64.94. A break below 62.71 would negate the upside evaluation.

TXN generated a negative week as well as a failure (or lack of confirmation) to the previous week's breakout to new all-time highs, having closed below the previous all-time weekly closing high at 220.29 (closed at 216.62). The stock closed slightly in the lower half of the week's trading range, suggesting a slightly higher probability of going below last week's low at 211.71 than above last week's high at 221.40. The company reports earnings this week on Tuesday after the close (I erroneously stated in last week's newsletter that it would be last Tuesday). Having said that, the action last week was unexpectedly negative and that has colored the short-term outlook in favor of the bears. In looking at "whales" option buying this past week, the bears are beating the bulls (puts vs calls) by 2-1. If last week's low is broken, there is no intraweek support below until 202.80 (very minor support). To the upside, last week's intraweek high is now indicative resistance.

VWDRY generated a positive reversal week, having gone below the previous week's low and then rallying 15% to make a new 8-month intraweek and weekly closing high. The stock closed on the high of the week, suggesting further upside above last week's high at 6.24 will be seen this week. The stock generated an indicative failure signal against the bears, having closed on Friday above a previous low weekly close of indicative consequence at 5.94 (closed at 6.19). On a daily closing basis, that level is 5.77. The next level of daily and weekly close resistance is at 6.51 and that level should be the objective this week. Having said that, the 6.51 level is also a previous low and as such, should not be considered a strong resistance. The 200-week MA is at 8.08 and it should be the next objective, to be reached over the next 4-8 weeks.

YUMC generated a negative week, having failed to follow through to the upside (as expected) and then closing red and in the lower half of the week's trading range, suggesting further downside below last week's low at 46.25 will be seen this week. The red weekly close means that the previous week's close at 47.60 is now a successful retest of the 200-week MA, currently at 47.63. The next intraweek support is found at 45.34, and that should be this week's objective. Any rally above the previous week's high at 48.36 would be considered bullish. The 200-day MA is currently at 46.70 and that has been a short-term pivotal line for the past 3-months, having closed above the line on 24 trading days and below the line on 37 trading days.

ZLAB generated a negative reversal week, having gone above the previous week's high and then closing on the low of the week, suggesting further downside below last week's low at 33.29 will be seen this week. The stock did generate a green weekly close but then only by $.84 cents, meaning that it was not an indicative green close. The stock did fall 8.5% from the high of the week and it was disappointing as the bulls gave up the small edge they had obtained the previous week. There was no news to support the weakness, in fact just the opposite as the Chinese index had a strong and indicative up week. On an intraweek basis, the recent low at 32.31, which if broken would suggest the 200-day MA, currently at 30.70, would be targeted. A daily close above 35.44 would negate this short-term bearish scenario.